Rule of Rescue

Last updated

The Rule of Rescue is a term coined by A.R. Jonsen in 1986 that is used in a variety of bioethics contexts: [1]

Contents

Criticism

The Rule of Rescue is heavily attacked by Shepley Orr and Jonathan Wolff in their article “Reconciling cost-effectiveness with the rule of rescue: the institutional division of moral labour”. [2] They argue the application of the rule leads to injustice and a suboptimal health outcome under the constraint of limited resources. They plead for strict application of cost-effectiveness analysis (QALYs) as solid base of decision making with priorities.

In order to avoid framing doctors in an “inhuman role” of deciding at the patients' bedside on the basis of cost effectiveness, they plead for “division of labour” between governments/institutions that allocate the resources on basis of cost effectiveness and doctors who try to save lives within given constraints, for which constraints they are not held personally responsible or liable.

Orr and Wolff conclude: “The rule of rescue has a strong intuitive pull. It seems to express our common humanity, and to refuse a rescue on grounds of cost appears morally horrendous, even in cases that do not share all the paradigm features of the rule of rescue. Yet at the same time in a complex, resource-constrained world, cost-effectiveness cannot be ignored. The two types of reasoning appear irreconcilable. We believe, however, that this appearance is misleading, and ordinary processes of medical decision making show how to reconcile the two. Resource allocation decision making broadly follows cost-effectiveness analysis (CEA), while emergency room and related ‘bedside’ decision-making is much closer to rescue reasoning. There is good reason for this division of labour, although we have conceded that this simple picture does need to be modified to accommodate the different ways in which both styles of reasoning take place in both venues. Nevertheless, the key point remains: cost-effectiveness analysis is needed to decide which tools of rescue to provide. Rescue can then take place in a manner apparently unconstrained by cost.“

“Reconciling the rule of rescue with cost-effectiveness” is important during pandemics.[ citation needed ] Most states have ignored cost-effectiveness analysis in applying lockdowns and delaying regular medical interventions with the “Rule of rescue”-argument during the 2020-2021 Covid-19 pandemic. [3]

Orr and Wolff in 2014 profoundly argued that the “Rule of rescue” is the result of wrong reasoning. Cost-effectiveness reasoning with the aid of QALYs always leads to moral superior outcomes and optimal public health outcome, given constraints of resources and competing interests. In an unconstrained situation without conflicting interests, the rule of rescue leads to rightly perceived results, without causing (macro) problems.

See also

Related Research Articles

<span class="mw-page-title-main">Microeconomics</span> Behavior of individuals and firms

Microeconomics is a branch of economics that studies the behavior of individuals and firms in making decisions regarding the allocation of scarce resources and the interactions among these individuals and firms. Microeconomics focuses on the study of individual markets, sectors, or industries as opposed to the national economy as a whole, which is studied in macroeconomics.

<span class="mw-page-title-main">Morality</span> Differentiation between right and wrong

Morality is the differentiation of intentions, decisions and actions between those that are distinguished as proper (right) and those that are improper (wrong). Morality can be a body of standards or principles derived from a code of conduct from a particular philosophy, religion or culture, or it can derive from a standard that a person believes should be universal. Morality may also be specifically synonymous with "goodness" or "rightness".

Cost-effectiveness analysis (CEA) is a form of economic analysis that compares the relative costs and outcomes (effects) of different courses of action. Cost-effectiveness analysis is distinct from cost–benefit analysis, which assigns a monetary value to the measure of effect. Cost-effectiveness analysis is often used in the field of health services, where it may be inappropriate to monetize health effect. Typically the CEA is expressed in terms of a ratio where the denominator is a gain in health from a measure and the numerator is the cost associated with the health gain. The most commonly used outcome measure is quality-adjusted life years (QALY).

The incremental cost-effectiveness ratio (ICER) is a statistic used in cost-effectiveness analysis to summarise the cost-effectiveness of a health care intervention. It is defined by the difference in cost between two possible interventions, divided by the difference in their effect. It represents the average incremental cost associated with 1 additional unit of the measure of effect. The ICER can be estimated as:

<span class="mw-page-title-main">Health economics</span> Branch of economics

Health economics is a branch of economics concerned with issues related to efficiency, effectiveness, value and behavior in the production and consumption of health and healthcare. Health economics is important in determining how to improve health outcomes and lifestyle patterns through interactions between individuals, healthcare providers and clinical settings. In broad terms, health economists study the functioning of healthcare systems and health-affecting behaviors such as smoking, diabetes, and obesity.

Utilitarian bioethics refers to the branch of bioethics that incorporates principles of utilitarianism to directing practices and resources where they will have the most usefulness and highest likelihood to produce happiness, in regards to medicine, health, and medical or biological research.

Cost–benefit analysis (CBA), sometimes also called benefit–cost analysis, is a systematic approach to estimating the strengths and weaknesses of alternatives. It is used to determine options which provide the best approach to achieving benefits while preserving savings in, for example, transactions, activities, and functional business requirements. A CBA may be used to compare completed or potential courses of action, and to estimate or evaluate the value against the cost of a decision, project, or policy. It is commonly used to evaluate business or policy decisions, commercial transactions, and project investments. For example, the U.S. Securities and Exchange Commission must conduct cost-benefit analyses before instituting regulations or deregulations.

Moral reasoning is the study of how people think about right and wrong and how they acquire and apply moral rules. It is a subdiscipline of moral psychology that overlaps with moral philosophy, and is the foundation of descriptive ethics.

<span class="mw-page-title-main">National Institute for Health and Care Excellence</span> Non-departmental public body of the Department of Health in the United Kingdom

The National Institute for Health and Care Excellence (NICE) is an executive non-departmental public body, in England, of the Department of Health and Social Care, that publishes guidelines in four areas:

<span class="mw-page-title-main">Preventive healthcare</span> Prevention of the occurrence of diseases

Preventive healthcare, or prophylaxis, is the application of healthcare measures to prevent diseases. Disease and disability are affected by environmental factors, genetic predisposition, disease agents, and lifestyle choices, and are dynamic processes that begin before individuals realize they are affected. Disease prevention relies on anticipatory actions that can be categorized as primal, primary, secondary, and tertiary prevention.

Cost–utility analysis (CUA) is a form of economic analysis used to guide procurement decisions. The most common and well-known application of this analysis is in pharmacoeconomics, especially health technology assessment (HTA).

<span class="mw-page-title-main">Quality-adjusted life year</span> Measure of disease burden

The quality-adjusted life year (QALY) is a generic measure of disease burden, including both the quality and the quantity of life lived. It is used in economic evaluation to assess the value of medical interventions. One QALY equates to one year in perfect health. QALY scores range from 1 to 0 (dead). QALYs can be used to inform health insurance coverage determinations, treatment decisions, to evaluate programs, and to set priorities for future programs.

<span class="mw-page-title-main">Disability-adjusted life year</span> Measure of disease burden

Disability-adjusted life years (DALYs) are a measure of overall disease burden, expressed as the number of years lost due to ill-health, disability, or early death. It was developed in the 1990s as a way of comparing the overall health and life expectancy of different countries.

Pharmacoeconomics refers to the scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another. It is a sub-discipline of health economics. A pharmacoeconomic study evaluates the cost and effects of a pharmaceutical product. Pharmacoeconomic studies serve to guide optimal healthcare resource allocation, in a standardized and scientifically grounded manner.

Comparative effectiveness research (CER) is the direct comparison of existing health care interventions to determine which work best for which patients and which pose the greatest benefits and harms. The core question of comparative effectiveness research is which treatment works best, for whom, and under what circumstances. Engaging various stakeholders in this process, while difficult, makes research more applicable through providing information that improves patient decision making.

Health care rationing refers to mechanisms that are used for resource allocation in health care.

<span class="mw-page-title-main">Management accounting principles</span> Management accounting case

Management accounting principles (MAP) were developed to serve the core needs of internal management to improve decision support objectives, internal business processes, resource application, customer value, and capacity utilization needed to achieve corporate goals in an optimal manner. Another term often used for management accounting principles for these purposes is managerial costing principles. The two management accounting principles are:

  1. Principle of Causality and,
  2. Principle of Analogy.

Decision quality (DQ) is the quality of a decision at the moment the decision is made, regardless of its outcome. Decision quality concepts permit the assurance of both effectiveness and efficiency in analyzing decision problems. In that sense, decision quality can be seen as an extension to decision analysis. Decision quality also describes the process that leads to a high-quality decision. Properly implemented, the DQ process enables capturing maximum value in uncertain and complex scenarios.

Distributional cost-effectiveness analysis (DCEA) is an extension of cost-effectiveness analysis (CEA) that incorporates concern for both the average levels of outcomes as well as the distribution of outcomes. It is particularly useful when evaluating interventions to tackle health inequality.

ISPOR—The Professional Society for Health Economics and Outcomes Research, better known as ISPOR, is a nonprofit global professional organization in health economics and outcomes research. It was founded in 1995 as an international multidisciplinary professional organization that advances the policy, science, and practice of pharmacoeconomics and outcomes research. The society's mission is to promote health economics and outcomes research to improve decision making for health globally.

References

  1. ↑ McKie, John & Jeff Richardson (2003) "The Rule of Rescue" Social Science & Medicine Volume 56, Issue 12, June 2003, Pages 2407-2419
  2. ↑ Orr, Shepley; Wolff, Jonathan (2015). "Reconciling cost-effectiveness with the rule of rescue: The institutional division of moral labour" (PDF). Theory and Decision. 78 (4): 525–538. doi: 10.1007/s11238-014-9434-3 . S2CID   18850681.
  3. ↑ see e.g. https://onlinelibrary.wiley.com/doi/full/10.1111/bioe.12771 and https://www.volkskrant.nl/columns-opinie/opinie-een-beleid-van-redden-nu-richt-op-termijn-alleen-maar-meer-coronaschade-aan~b6071d49/
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.